Current and future applications of the intra-aortic balloon pump

Current Opinion in Cardiology

Volumn 29, Issue 3, 2014, Pages 258-265

  Kapelios, Chris J ^a   Terrovitis, John V ^a   Nanas, John N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

bridge to transplantation; cardiogenic shock; heart failure; intra aortic balloon pump; intra aortic counterpulsation

Indexed keywords

ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; AXILLARY ARTERY; CARDIOGENIC SHOCK; COMPARATIVE STUDY; FEASIBILITY STUDY; HIGH RISK PATIENT; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL DEVICE COMPLICATION; META ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SUBCLAVIAN ARTERY; CLINICAL TRIAL (TOPIC); COMPLICATION; HEART INFARCTION; HEART TRANSPLANTATION; PATHOPHYSIOLOGY; PREOPERATIVE CARE; PROCEDURES; RISK ASSESSMENT; SHOCK, CARDIOGENIC; STATISTICS AND NUMERICAL DATA;

CLINICAL TRIALS AS TOPIC; HEART TRANSPLANTATION; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE CARE; RISK ADJUSTMENT; SHOCK, CARDIOGENIC;

EID: 84899479110     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000059     Document Type: Review

References (58)

1. Moulopoulos SD, Topaz S, Kolff WJ. Diastolic balloon pumping (with carbon dioxide) in the aorta-a mechanical assistance to the failing circulation. Am Heart J 1962; 63:669-675.
2. Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968; 203:113-118.
3. O'Malley P. Hemodynamic outcomes of weaning intraaortic balloon counterpulsation in heart failure. Graduate Department. Ohio: The Ohio State University; 2000; 161.
4. Sarkar K, Kini AS. Percutaneous left ventricular support devices. Cardiol Clin 2010; 28:169-184.
5. Ferguson JJ 3rd, Cohen M, Freedman RJ Jr, et al. The current practice of intraaortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 2001; 38:1456-1462.
6. Stone GW, Ohman EM, Miller MF, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the BENCHMARK registry. J Am Coll Cardiol 2003; 41:1940-1945.
7. Kovack PJ, Rasak MA, Bates ER, et al. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997; 29:1454-1458.
8. Barron HV, Every NR, Parsons LS, et al., Investigators in the National Registry of Myocardial Infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141:933-939.
9. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000; 36 (3 Suppl A):1123-1129.
10. Ohman EM, Nanas J, Stomel RJ, et al., TACTICS Trial. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 2005; 19:33-39.
11. Chen EW, Canto JG, Parsons LS, et al. Investigators in the National Registry of Myocardial Infarction 2. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation 2003; 108:951-957.
12. Zeymer U, Bauer T, Hamm C, et al. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI. Euro Intervention 2011; 7:437-441.
13. Zeymer U, Hochadel M, Hauptmann KE, et al. Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry. Clin Res Cardiol 2013; 102:223-227.
14. Prondzinsky R, Unverzagt S, Russ M, et al. Hemodynamic effects of intraaortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 2012; 37:378-384.
15. Thiele H, Zeymer U, Neumann FJ, et al., the IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367:1287-1296.
16. Thiele H, Zeymer U, Neumann FJ, et al., Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013; 382:1638-1645.
17. Widimsky P, Wijns W, Fajadet J, et al., European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010; 31:943-957.
18. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009; 54:281-292.
19. Reffelmann T, Kloner RA. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 2002; 283:H1099-1107.
20. Pierrakos CN, Bonios MJ, Drakos SG, et al. Mechanical assistance by intraaortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study. Artif Organs 2011; 35:867-874.
21. Abdel-Wahab M, Saad M, Kynast J, et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2010; 105:967-971.
22. Kettner J, Sramko M, Holek M, et al. Utility of intra-aortic balloon pump support for ventricular septal rupture and acute mitral regurgitation complicating acute myocardial infarction. Am J Cardiol 2013; 112:1709-1713.
23. Romeo F, Acconcia MC, Sergi D, et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive metaanalysis. Am Heart J 2013; 165:679-692.
24. Sjauw KD, Engström AE, Vis MM, et al. Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock. Neth Heart J 2012; 20:402-409.
25. Cheng JM, van Leeuwen MA, de Boer SP, et al. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction. Int J Cardiol 2013; 168:3758-3763.
26. Nanas JN, Nanas SN, Kontoyannis DA, et al. Myocardial salvage by the use of reperfusion and intraaortic balloon pump: experimental study. Ann Thorac Surg 1996; 61:629-634.
27. Briguori C, Sarais C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003; 145:700-707.
28. van 't Hof AW, Liem AL, de Boer MJ, et al. A randomized comparison of intraaortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J 1999; 20:659-665.
29. Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (Pacute MI-II) Trial Investigators. J Am Coll Cardiol 1997; 29:1459-1467.
30. Mahmoudi M, Hauville C, Gaglia MA Jr, et al. The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock. Cardiovasc Revasc Med 2012; 13:328-330.
31. Mishra S, Chu WW, Torguson R. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006; 98:608-612.
32. Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP acute MI randomized trial. JAMA 2011; 306:1329-1337.
33. Perera D, Stables R, Thomas M, et al., BCIS-1 Investigators. Elective intraaortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA 2010; 304:867-874.
34. Perera D, Stables R, Clayton T, et al., BCIS-1 Investigators. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation 2013; 127: 207-212.
35. Werdan K, Gielen S, Ebelt H, Hochman JS. Mechanical circulatory support in cardiogenic shock. Eur Heart J 2014; 35:156-167.
36. Manzo-Silberman S, Fichet J, Mathonnet A, et al. Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra aortic blood pump and IMPELLA Recover LP 2.5. Resuscitation 2013; 84:609-615.
37. O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012; 126:1717-1727.
38. Kormos RL, Teuteberg JJ, Pagani FD, et al., HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010; 139:1316-1324.
39. Raina A, Seetha Rammohan HR, Gertz ZM, et al. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters. J Card Fail 2013; 19:16-24.
40. Romano MA, Cowger J, Aaronson KD, Pagani FD. Diagnosis and management of right-sided heart failure in subjects supported with left ventricular assist devices. Curr Treat Options Cardiovasc Med 2010; 12:420-430.
41. Arafa OE, Geiran OR, Andersen K, et al. Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg 2000; 70:1587-1593.
42. Kapelios C, Terrovitis J, Ntalianis A, et al. Intra-aortic balloon pump improves right ventricular function in patients with end-stage congestive heart failure [Abstract]. Circulation 2013; 128:A18182.
43. Gjesdal O, Gude E, Arora S, et al. Intra-aortic balloon counterpulsation as a bridge to heart transplantation does not impair long-term survival. Eur J Heart Fail 2009; 11:709-714.
44. Cochran RP, Starkey TD, Panos AL, Kunzelman KS. Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann Thorac Surg 2002; 74:746-751.
45. Russo MJ, Jeevanandam V, Stepney J, et al. Intra-aortic balloon pump inserted through the subclavian artery: a minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg 2012; 144:951-955.
46. Umakanthan R, Hoff SJ, Solenkova N, et al. Benefits of ambulatory axillary intra-aortic balloon pump for circulatory support as bridge to heart transplant. J Thorac Cardiovasc Surg 2012; 143:1193-1197.
47. Estep JD, Cordero-Reyes AM, Bhimaraj A, et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail 2013; 1:382-388.
48. Pucher PH, Cummings IG, Shipolini AR, McCormack DJ. Is heparin needed for patients with an intra-aortic balloon pump? Interact Cardiovasc Thorac Surg 2012; 15:136-139.
49. Krishna M, Zacharowski K. Principles of intra-aortic balloon pump counterpulsation. Cont Educ Anaesth Crit Care Pain 2009; 9:24-28.
50. Goldich G. Getting in sync with intra-aortic balloon pump therapy. Nursing Crit Care 2011; 6:14-19.
51. Pantalos GM, Koenig SC, Gillars KJ, et al. Intraaortic balloon pump timing discrepancies in adult patients. Artif Organs 2011; 35:857-866.
52. Kantrowitz A, Cardona RR, Freed PS. Weaning from the intraaortic balloon pump. In: Quaal SJ, editor. Comprehensive intraaortic balloon counterpulsation. 2nd ed. St Louis, MO: Mosby Inc; 1993. pp. 398-407.
53. Fuchs RM, Brin KP, Brinker JA, et al. Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina. Circulation 1983; 68:117-123.
54. Cheung AT, Savino JS, Weiss SJ. Beat-to-beat augmentation of left ventricular function by intra-aortic counterpulsation. Anesthesiology 1996; 84: 545-554.
55. Gelsomino S, Renzulli A, Rubino AS, et al. Effects of 1:1, 1:2 or 1:3 intra-aortic balloon counterpulsation/heart support on coronary haemodynamics and cardiac contractile efficiency in an animal model of myocardial ischaemia/reperfusion. Eur J Cardiothorac Surg 2012; 42:325-332.
56. Manohar VA, Levin RN, Karadolian SS, et al. The impact of intra-aortic balloon pump weaning protocols on in-hospital clinical outcomes. J Interv Cardiol 2012; 25:140-146.
57. Hsin HT, Chen LY, Lin PC, et al. Central venous oxygen saturation (ScVO2) facilitates the weaning of intra-aortic balloon pump in acute heart failure related to acute myocardial infarction. Int J Cardiol 2013; 168: 4568-4570.
58. Thiele H, Allam B, Chatellier G, et al. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 2010; 31:1828-1835.